IR vs LAB · P/E 49, rev $7.24B vs rev $174.4M
Ingersoll Rand Inc (IR) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
IR currently screens at market cap $28.27B and trailing P/E 48.8. LAB currently screens at market cap $317.1M.
Not investment advice. Open the IR and LAB stock pages for the full models.
Not investment advice.